Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117084) titled 'Imaging Markers of High-Risk Plaque Phenotype for Predicting Post-PCI Outcomes' on Aug. 5.
Study Type: Observational
Primary Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Condition:
Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)
Atherosclerosis of Coronary Artery
Intervention:
Diagnostic Test: CCTA-derived Plaque Quantification
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2021
Target Sample Size: 2000
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117084
Published by HT Digital Content Services with ...